
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 10, 2025, titled "Cosmo and Glenmark Announce UK MHRA Approval of Winlevi? for Treatment of Acne".
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 10, 2025, titled "Cosmo and Glenmark Announce UK MHRA Approval of Winlevi? for Treatment of Acne".
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals